Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹1,029.00
Market cap
₹2,160 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
32.5×Sector 47.4×
Promoter holding
63.31%+1.41% QoQ
FII holding
2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22:44 IST BSE
Adverse Business Impact

Windlas Biotech Adverse Business Impact

Windlas Biotech reported temporary production disruptions due to statewide labour unrest in Uttarakhand. Operations resumed quickly with management expecting no material impact on financial performance.